Search Results - Olaya de Dios

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators by Berta Segura-Collar, Sara Hiller-Vallina, Olaya de Dios, Marta Caamaño-Moreno, Lucia Mondejar-Ruescas, Juan M. Sepulveda-Sanchez, Ricardo Gargini

    Published in Acta Neuropathologica Communications (2023-05-01)
    Get full text
    Article


  2. 2

    Sex-dependent relationship of polymorphisms in CLOCK and REV-ERBα genes with body mass index and lipid levels in children by Claudia Vales-Villamarín, Olaya de Dios, Ignacio Mahíllo-Fernández, Macarena Perales, Iris Pérez-Nadador, Teresa Gavela-Pérez, Leandro Soriano-Guillén, Carmen Garcés

    Published in Scientific Reports (2023-12-01)
    Get full text
    Article


  3. 3

    VP3.15, a dual GSK-3β/PDE7 inhibitor, reduces glioblastoma tumor growth though changes in the tumor microenvironment in a PTEN wild-type context by Maria Castello-Pons, Maria A. Ramirez-Gonzalez, Patricia Iglesias-Hernández, Nermina Logo Lendo, Carlos Rodriguez-Martín, Laura Quiralte, Juan-Manuel Sepúlveda-Sánchez, Olaya de Dios, Carmen Gil, Ana Martínez, Pilar Sánchez-Gómez, Sergio Casas-Tinto

    Published in Neurotherapeutics (2025-07-01)
    Get full text
    Article


  4. 4

    NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma by Derek A Wainwright, Aurelio Hernández-Laín, Maria E Rodriguez-Ruiz, Olaya de Dios, Carlos E De Andrea, Angel Pérez-Nuñez, Diego Megías, M Angeles Ramírez-González, Irene Gómez-Soria, Berta Segura-Collar, Juliana Manosalva, Leticia Fernández-Rubio, Juan M Sepúlveda-Sánchez, Ricardo Gargini, Pilar Sánchez-Gómez

    Published in Journal for ImmunoTherapy of Cancer (2024-08-01)
    Get full text
    Article


Search Tools: